Non-stem cell lineages as an alternative origin of intestinal tumorigenesis in the context of inflammation

Nat Genet. 2024 Jul;56(7):1456-1467. doi: 10.1038/s41588-024-01801-y. Epub 2024 Jun 20.

Abstract

According to conventional views, colon cancer originates from stem cells. However, inflammation, a key risk factor for colon cancer, has been shown to suppress intestinal stemness. Here, we used Paneth cells as a model to assess the capacity of differentiated lineages to trigger tumorigenesis in the context of inflammation in mice. Upon inflammation, Paneth cell-specific Apc mutations led to intestinal tumors reminiscent not only of those arising in patients with inflammatory bowel disease, but also of a larger fraction of human sporadic colon cancers. The latter is possibly because of the inflammatory consequences of western-style dietary habits, a major colon cancer risk factor. Machine learning methods designed to predict the cell-of-origin of cancer from patient-derived tumor samples confirmed that, in a substantial fraction of sporadic cases, the origins of colon cancer reside in secretory lineages and not in stem cells.

MeSH terms

  • Adenomatous Polyposis Coli Protein / genetics
  • Animals
  • Carcinogenesis* / genetics
  • Cell Differentiation / genetics
  • Cell Lineage* / genetics
  • Cell Transformation, Neoplastic / genetics
  • Colonic Neoplasms* / genetics
  • Colonic Neoplasms* / pathology
  • Humans
  • Inflammation* / genetics
  • Inflammation* / pathology
  • Inflammatory Bowel Diseases / genetics
  • Inflammatory Bowel Diseases / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mutation
  • Paneth Cells* / pathology
  • Stem Cells / pathology

Substances

  • Adenomatous Polyposis Coli Protein